Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.

Mills SC, Haq M, Smellie WJ, Harmer C.

Eur J Surg Oncol. 2009 Mar;35(3):230-4. doi: 10.1016/j.ejso.2008.06.007. Epub 2008 Aug 21.

PMID:
18722077
2.

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, Sherman SI.

Cancer. 2003 Mar 1;97(5):1186-94.

3.

Hurthle cell neoplasm of the thyroid gland.

Ahmed M, Bin Yousef H, Greer W, Faraz H, Al Sobhi S, Al Zahrani A, Raef H, Al Ghamdi A, Al Kadhi Y, Al Dayel F.

ANZ J Surg. 2008 Mar;78(3):139-43. doi: 10.1111/j.1445-2197.2007.04389.x.

PMID:
18269475
4.

Hürthle cell carcinoma: a clinicopathological study of thirteen cases.

Ozlem Küçük N, Kulak H, Tokmak E, Tar P, Ibiş E, Aras G.

Nucl Med Commun. 2006 Apr;27(4):377-9.

PMID:
16531925
5.
6.

Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.

Cappelli C, Pirola I, Braga M, De Martino E, Morassi ML, Gandossi E, Mattanza C, Balzano R, Castellano M, Rosei EA.

Ann Ital Chir. 2006 Mar-Apr;77(2):107-13.

PMID:
17147082
7.

Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.

Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B.

Cancer. 2006 Apr 15;106(8):1669-76.

8.

Hürthle cell carcinoma: a 60-year experience.

Stojadinovic A, Hoos A, Ghossein RA, Urist MJ, Leung DH, Spiro RH, Shah JP, Brennan MF, Singh B, Shaha AR.

Ann Surg Oncol. 2002 Mar;9(2):197-203.

PMID:
11888879
9.

Long-term results in elderly patients with differentiated thyroid carcinoma.

Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C.

Cancer. 2003 Jun 1;97(11):2736-42.

10.

Papillary thyroid carcinoma: factors influencing recurrence and survival.

Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M.

Ann Surg Oncol. 2008 May;15(5):1518-22. doi: 10.1245/s10434-008-9859-4. Epub 2008 Mar 7.

PMID:
18324441
11.

Hürthle cell carcinoma: a critical histopathologic appraisal.

Stojadinovic A, Ghossein RA, Hoos A, Urist MJ, Spiro RH, Shah JP, Brennan MF, Shaha AR, Singh B.

J Clin Oncol. 2001 May 15;19(10):2616-25.

PMID:
11352953
12.

Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid.

Zhang YW, Greenblatt DY, Repplinger D, Bargren A, Adler JT, Sippel RS, Chen H.

Ann Surg Oncol. 2008 Oct;15(10):2842-6. doi: 10.1245/s10434-008-0079-8. Epub 2008 Jul 30.

PMID:
18665423
13.

Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.

Lang BH, Lo CY, Chan WF, Lam KY, Wan KY.

Ann Surg Oncol. 2007 Feb;14(2):730-8. Epub 2006 Nov 11.

PMID:
17103065
14.

Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.

Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR.

J Am Coll Surg. 2003 Aug;197(2):191-7.

PMID:
12892796
15.

Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients.

Pelizzo MR, Boschin IM, Toniato A, Piotto A, Pagetta C, Gross MD, Al-Nahhas A, Rubello D.

Clin Nucl Med. 2007 Jun;32(6):440-4.

PMID:
17515749
16.

Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer.

Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH.

Am J Surg. 2008 Apr;195(4):457-62.

PMID:
18070728
17.
18.

Surgery for thyroid Hürthle cell tumours--a single institution experience.

Paunovic I, Krgovic K, Tatic S, Diklic A, Zivaljevic V, Kalezic N, Havelka M.

Eur J Surg Oncol. 2006 May;32(4):458-61. Epub 2006 Feb 23.

PMID:
16497473
19.

Survival and prognosis in Hürthle cell carcinoma of the thyroid gland.

Bhattacharyya N.

Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):207-10.

PMID:
12578450
20.

Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.

Verburg FA, Mäder U, Luster M, Reiners C.

Eur J Endocrinol. 2009 Apr;160(4):619-24. doi: 10.1530/EJE-08-0805. Epub 2009 Jan 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk